Condition

End-stage Kidney Disease

ClinicalTrials.gov condition label

Clinical trials6

Recruiting1

Common interventions8

Lead sponsors shown6

Clinical trials

6 shown

Staged Kidney Transplantation During Combined Heart/Kidney TransplantationNCT06877169 · 2025-04-07

Exercise and Cardiac Stunning During HDNCT04877041 · 2023-03-01

Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)NCT02933697 · 2017-06-20

Optimizing Kidney Transplant Informed ConsentNCT01859884 · 2013-10-01

Vascular Protective Effect of Rosuvastatin in Arteriovenous FistulaNCT01863914 · 2012-11-01

Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis PatientsNCT01528800 · 2012-11-01

Common interventions

ApixabanDRUG1 Inform Me: web-based education toolBEHAVIORAL1 Intradialytic CyclingBEHAVIORAL1 Microcrystalline MethylcelluloseDRUG1 PhenprocoumonDRUG1 Planned delayed implantation of kidney allograft with ex vivo machine perfusion kidney preservation.OTHER1 RosuvastatinDRUG1 Vitamin K1DRUG1

Leading sponsors

Atrial Fibrillation Network1 Cedars-Sinai Medical Center1 Dr. Rachel Holden1 National Cheng-Kung University Hospital1 Northwestern University1 University of Manitoba1

Trial status mix

COMPLETED5

RECRUITING1

Phase mix

NA3

PHASE22

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.